Clinical Trials List
2024-02-12 - 2026-06-01
Phase III
Recruiting5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 高宗楙 Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 謝祖怡 Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 顏在弘 Division of Rheumatology
- 林靖才 Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- Yi-Hsing Chen Division of Rheumatology
- 廖育婉 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林科宏 Division of Rheumatology
- Tzn-Min Lin Division of Rheumatology
- 林韋睿 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ping-Han Tsai Division of Rheumatology
- Shue-Fen Lo Division of Rheumatology
- 陳彥輔 Division of Rheumatology
- 張哲慈 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Po-Hao Huang 風濕免疫科
- 黃建中 風濕免疫科
- 張詩欣 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 歐燦騰 風濕免疫科
- Jeng-Hsien Yen 風濕免疫科
- Chia-Chun Tseng 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
435 participants
